March 19, 2010 — Neoadjuvant treatment with Taxotere® (docetaxel) and Emcyt® (estramustine) for high-risk localized prostate cancer appears to be safe and produces promising responses compared with standard treatment, according to the results of a Phase III randomized study presented at the 2010 Genitourinary Cancers Symposium in San Francisco.

March 19, 2010 — Researchers from several U.S. medical centers have reported that “specialist visits relate strongly to prostate cancer treatment choices.” The details of this study were published in the March 8, 2010 issue of the Archives of Internal Medicine.

March 19, 2010 — Researchers from the University of Michigan have reported that current tobacco users with advanced, human papillomavirus (HPV)-positive oropharyngeal cancer are at increased risk of disease recurrence. The details of this study were published in the February 15, 2010 issue of Clinical Cancer Research.